ArticleBreast cancer research and treatment2025

Real-world neoadjuvant and adjuvant Trastuzumab-containing regimen patterns and their association with survival among patients with operable HER2-positive breast cancer from 2007 to 2021.

Hui Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.